How new price transparency rules affect hospital prices
Effects of Negotiated Price Transparency Regulations: Evidence from Hospital Prices
This study looks at how new rules that make hospitals share their prices with insurance companies affect how much you pay for healthcare and the choices you have, helping us understand if being able to see prices makes care more affordable or if it might actually raise costs.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project ID | NIH-10733271 on NIH RePORTER |
What this research studies
This research investigates the impact of recent regulations requiring hospitals to publicly disclose their negotiated prices with insurers. By analyzing the effects of these transparency rules, the study aims to understand how they influence healthcare affordability and patient choices. The research will explore whether increased price visibility leads to lower costs for patients or if it inadvertently results in higher prices due to market dynamics. The findings could provide valuable insights into the relationship between price transparency and healthcare spending.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with private health insurance who are affected by hospital pricing and transparency regulations.
Not a fit: Patients who are uninsured or rely on government insurance programs may not benefit directly from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved healthcare affordability and better-informed patient choices.
How similar studies have performed: While the effects of price transparency in healthcare have been discussed, this specific approach to studying its impact is relatively novel and has not been rigorously tested.
Where this research is happening
Durham, United States
- Duke University — Durham, United States (Active)
Researchers
- Principal investigator: Behrer, Christopher — Duke University
- Study coordinator: Behrer, Christopher
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.